Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 11 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 13 most recent Form 4 transactions.
| NTLA |
| Intellia Therapeutics,… |
| AGRANT◆ |
| 13,300 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Jun 9 | NTLA | Intellia Therapeutics,… | AGRANT | 9,200 | — | — | +6.8% | Open the original filing on SEC.gov |
| Apr 15 | GRAL | GRAIL, Inc. | AGRANT | 408 | $49.79 | $20.3K | +1.1% | Open the original filing on SEC.gov |
| Jan 15 | GRAL | GRAIL, Inc. | AGRANT | 213 | $97.44 | $20.8K | +0.6% | Open the original filing on SEC.gov |
| Oct 15, 2025 | GRAL | GRAIL, Inc. | AGRANT | 275 | $75.52 | $20.8K | +0.8% | Open the original filing on SEC.gov |
| Aug 20, 2025 | NTLA | Intellia Therapeutics,… | PBUY | 100,000 | $10.03 | $1M | +288.2% | Open the original filing on SEC.gov |
| Jul 15, 2025 | GRAL | GRAIL, Inc. | AGRANT | 533 | $38.53 | $20.5K | +1.5% | Open the original filing on SEC.gov |
| Jun 11, 2025 | NTLA | Intellia Therapeutics,… | AGRANT◆ | 11,450 | — | — | — | Open the original filing on SEC.gov |
| Jun 11, 2025 | NTLA | Intellia Therapeutics,… | AGRANT | 8,000 | — | — | +30.0% | Open the original filing on SEC.gov |
| May 29, 2025 | GRAL | GRAIL, Inc. | AGRANT | 6,082 | $41.10 | $250K | +20.5% | Open the original filing on SEC.gov |
| Apr 15, 2025 | GRAL | GRAIL, Inc. | AGRANT | 784 | $25.94 | $20.3K | +2.7% | Open the original filing on SEC.gov |